GlassScriptPhysician profile
Mikhail Kirnus
NPI 1922272228
$16,418.26
in general payments reported to CMS, 2019-2025
29 companies · $2,510 in 2025
The $2,510 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,158 · 2020: $629 · 2021: $1,615 · 2022: $6,453 · 2023: $1,693 · 2024: $2,361 · 2025: $2,510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,551 · Travel and Lodging: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,551.49 |
| Travel and Lodging | $1,012.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,590.43 | 2020-2023 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $3,476.73 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merit Medical Systems INC | $1,851.61 | 2022 | |
| Boston Scientific Corporation | $1,703.78 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Comet |
| Medtronic, INC. | $1,341.24 | 2021-2023 | Corevalve Evolut R, Amplia Mri Quad Crt-D Surescan |
| Abiomed | $958.86 | 2019-2025 | Impella |
| Philips North America LLC | $949.91 | 2019-2025 | Igt Devices Undivided, Coronary Undivided |
| Abbott Laboratories | $587.10 | 2019-2025 | Dragonfly Opstar, Xience Skypoint |
| Opsens INC. | $301.09 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $297.53 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.80 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $193.38 | 2020 | |
| Heartflow, INC. | $144.42 | 2023 | Ffrct |
| United Therapeutics Corporation | $87.85 | 2023 | |
| Cardinal Health 200 LLC | $85.80 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $85.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $82.25 | 2022-2025 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $73.17 | 2019-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $67.87 | 2019-2024 | |
| Angiodynamics, INC. | $59.71 | 2025 | Alphavac |
| Sanofi-Aventis U.S. LLC | $57.35 | 2019 | |
| Lundbeck LLC | $45.10 | 2019 | |
| Amgen INC. | $26.27 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.48 | 2019 | |
| Terumo Medical Corporation | $17.54 | 2025 | Glidesheath Slender, Angio-Seal |
| Amarin Pharma, INC. | $15.62 | 2019 | |
| Lantheus Medical Imaging, INC. | $14.80 | 2024 | |
| Cardiovascular Systems INC. | $13.76 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikhail Kirnus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.